ISRAEL21c11d
Gene editing may be key to treating head and neck cancers
CRISPR technique can target single genes essential for cancer cell survival, toppling the whole structure, says nanomedicine ...
Fierce Pharma15h
For struggling cell and gene therapy field, Peter Marks' FDA exit adds even more uncertainty
The sudden resignation of Peter Marks, M.D., Ph.D., from the FDA branch that regulates biological products for humans ...
Managed Healthcare Executive6d
Death of Elevidys Patient Rattles Duchenne Community
The patient died of acute liver failure; the maker of the gene therapy noted that the patient also had a recent ...
BioSpace7d
Safety Questions Loom in Duchenne as Dyne, Wave and Others Plan FDA Filings
Several companies will head to the FDA seeking approval of new Duchenne muscular dystrophy treatments next year but the death ...
BioWorld7d
PBGENE-DMD restores dystrophin functioning in DMD
Precision Biosciences Inc. recently presented a new gene-editing approach, PBGENE-DMD, which could allow life-long benefits to patients with Duchenne muscular dystrophy (DMD).
New light-controlled CRISPR tool enhances precision in genetic research
A team of researchers at Karolinska Institutet has developed a novel tool for genetic research. The study, published in ...